Recently, evidence for gadolinium retention in the brain was provided, raising concerns regarding the safety of these agents. This accumulation raised important questions, most crucially, by which pathway does gadolinium enter the brain. We provide insight into this by dynamic monitoring of the infiltration and clearance of gadolinium into the brain parenchyma following an IV injection. Following gadolinium injection, inflow of contrast into the cerebrospinal fluid spaces was prominent. 25mins post injection, contrast enhancement is detected in the periventricular regions and hypothalamus. This finding provides insight into the entry routes by which gadolinium infiltrates the brain following a systemic administration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords